2025 annual financial data

Eupraxia Pharmaceuticals 2025 Operating margin

Eupraxia Pharmaceuticals 2025 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -53,659,677 USD and net income was -53,858,075 USD.
Operating cash flow was -29,028,363 USD.

Get free Eupraxia Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-53,659,677 USD
Net income
-53,858,075 USD
Operating cash flow
-29,028,363 USD